Ebola Therapeutic Study and Future Directions.

Area of Science:

• Virology
• Epidemiology
• Biomedical Research

Background:

• Ebola virus disease (EVD) outbreaks in Africa cause global panic due to high mortality rates (30-70%).
• Current medical interventions for EVD are limited, highlighting an urgent need for effective treatments.
• Existing patented agents and biotherapies require re-evaluation for global market reintroduction.

Purpose of the Study:

• To review and promote biomedical research on Ebola virus disease.
• To outline the multifaceted aspects of Ebola infections, including origin, pathology, and genomic changes.
• To discuss the therapeutic context and economic considerations for combating Ebola.

Main Methods:

• Review of existing literature on Ebola virus disease.
• Analysis of patented therapeutic agents, biotherapies, and vaccines.
• Examination of potential mechanisms of action for various treatment options.
• Discussion of the origin, pathologic progress, genomic changes, and economic factors related to Ebola.

Main Results:

• Identified a critical need to revive and reintroduce diverse therapeutic agents, including small molecules, nucleic acid-based therapies, and herbal medicines.
• Highlighted ongoing research into the mechanisms of action for potential Ebola treatments.
• Provided a comprehensive overview of Ebola infection characteristics relevant to therapeutic development.

Conclusions:

• Revitalizing patented agents, biotherapies, and vaccines is crucial for addressing the Ebola epidemic.
• Further research into therapeutic mechanisms and economic viability is essential.
• A multifaceted approach encompassing origin, pathology, genomics, and economics is needed to combat Ebola effectively.